Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-20-006330
Filing Date
2020-01-23
Accepted
2020-01-23 16:26:22
Documents
3
Group Members
AVISTA HEALTHCARE PARTNERS GP, LTD.AVISTA HEALTHCARE PARTNERS, L.P.ORBIT CO-INVEST I LLCORBIT CO-INVEST III LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D a20-5528_1sc13d.htm SC 13D 152391
2 EX-1 a20-5528_1ex1.htm EX-1 20300
3 EX-2 a20-5528_1ex2.htm EX-2 420134
  Complete submission text file 0001104659-20-006330.txt   594540
Mailing Address C/O AVISTA CAPITAL PARTNERS, 65 EAST 55T NEW YORK NY 10022
Business Address C/O AVISTA CAPITAL PARTNERS, 65 EAST 55T NEW YORK NY 10022 2125936900
Avista Capital Partners III GP, L.P. (Filed by) CIK: 0001705722 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Subject) CIK: 0001739426 (see all company filings)

EIN.: 000000000
Type: SC 13D | Act: 34 | File No.: 005-90830 | Film No.: 20542452
SIC: 2834 Pharmaceutical Preparations